Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03111927 · ClinicalTrials.gov registry record · NA
Infant Nutrition and Brain Development
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 189
- Enrollment target
NCT03111927 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 189 participants.
The verdict
NCT03111927, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 189 participants
- Enrollment target
Study Summary
Research study on the role of early life nutrition on brain and cognitive development during infancy and early childhood. Two blends of myelin-relevant nutrients at different levels were compared and a breastfed group was considered as epidemiological reference.
Interventions
- OTHER Infant Formula: enriched level of myelin-relevant nutrients
- OTHER Infant formula: standard level of myelin-relevant nutrients
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 189 participants |
| Start Date | 2017-03-13 |
| Est. Completion | 2022-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03111927
The ClinicalTrials.gov registry entry for NCT03111927 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 189 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Infant Formula: enriched level of myelin-relevant nutrients is the first listed.
NCT03111927 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03111927 about?
NCT03111927 is a clinical study titled "Infant Nutrition and Brain Development". Research study on the role of early life nutrition on brain and cognitive development during infancy and early childhood. Two blends of myelin-relevant nutrients at different levels were compared and a breastfed group was considered as epidemiological reference.
What is the current status of trial NCT03111927?
This trial is currently completed. It is a NA study. The enrollment target is 189 participants. The study started on 2017-03-13. Estimated completion is 2022-02-28.
What interventions are being tested in trial NCT03111927?
The interventions under investigation include: Infant Formula: enriched level of myelin-relevant nutrients (OTHER), Infant formula: standard level of myelin-relevant nutrients (OTHER).
Who is sponsoring clinical trial NCT03111927?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.